Range
1.33 - 1.44
Vol / Avg.
3.8M/4.6M
Div / Yield
-
52 Wk
0.45 - 2.26
Mkt Cap
336.8M
Payout Ratio
-
Open
1.42
P/E
-
EPS
-0.06
Shares
251.4M
Outstanding
251.4M
Total Float
215.6M
Benzinga - 6 days ago
Benzinga - Jun 4, 2021, 8:12AM
Benzinga - May 26, 2021, 1:24PM
Benzinga - May 17, 2021, 7:34AM
Benzinga - May 13, 2021, 7:45AM
Benzinga - Apr 21, 2021, 7:33AM
Benzinga - Apr 19, 2021, 7:31AM
Benzinga - Apr 12, 2021, 7:36AM
Benzinga - Apr 7, 2021, 7:21AM
Benzinga - Apr 6, 2021, 4:32PM
Benzinga - Apr 6, 2021, 4:18PM
Benzinga - Mar 31, 2021, 7:19AM
Benzinga - Mar 30, 2021, 4:35PM
Benzinga - Mar 30, 2021, 4:33PM
Benzinga - Mar 25, 2021, 11:56AM
Benzinga - Mar 23, 2021, 9:19AM
Benzinga - Mar 23, 2021, 7:47AM
Benzinga - Mar 22, 2021, 4:17PM
Benzinga - Mar 9, 2021, 7:51AM
load more
Sector: Health Care.Industry: Pharmaceuticals
9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003 and others.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.030-0.030 0.0000
REV0
Q4 2020Est.ActualSurprise
EPS-0.030
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
NMTR9 Meters Biopharma-6.29%336.8M

9 Meters Biopharma Frequently Asked Questions

Q

How do I buy 9 Meters Biopharma (NMTR) stock?

A

You can purchase shares of 9 Meters Biopharma (NASDAQ: NMTR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are 9 Meters Biopharma's (NMTR) competitors?

A

Other companies in 9 Meters Biopharma’s space includes: Iterum Therapeutics (NASDAQ:ITRM), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), BioDelivery Sciences Intl (NASDAQ:BDSI) and CymaBay Therapeutics (NASDAQ:CBAY).

Q

What is the target price for 9 Meters Biopharma (NMTR) stock?

A

The latest price target for 9 Meters Biopharma (NASDAQ: NMTR) was reported by Citigroup on June 4, 2021. The analyst firm set a price target for 3.00 expecting NMTR to rise to within 12 months (a possible 123.88% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for 9 Meters Biopharma (NMTR)?

A

The stock price for 9 Meters Biopharma (NASDAQ: NMTR) is $1.34 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does 9 Meters Biopharma (NMTR) pay a dividend?

A

There are no upcoming dividends for 9 Meters Biopharma.

Q

When is 9 Meters Biopharma (NASDAQ:NMTR) reporting earnings?

A
9 Meters Biopharma’s Q2 earnings are confirmed for after-market on August 11, 2021.
Q

Is 9 Meters Biopharma (NMTR) going to split?

A

There is no upcoming split for 9 Meters Biopharma.

Q

What sector and industry does 9 Meters Biopharma (NMTR) operate in?

A

9 Meters Biopharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.